SARS/CoV-2: Behavioral Host Manipulation

Adv Exp Med Biol. 2021:1353:71-80. doi: 10.1007/978-3-030-85113-2_4.

Abstract

Introduction: Though it has not been extensively studied, host manipulation has been documented for various pathogens. Examples of this phenomenon can be seen in cases of toxoplasmosis, rabies, and the influenza virus. An examination of the possible means by which SARS/CoV-2 alters the behavior of its host to spread among populations is elaborated. Indirect evidence that serves as indicators of this phenomenon is presented.

Methods: This is primarily a theoretical document. Many of the ideas raised are not amenable to direct testing due to ethical concerns. However, several indirect means by which to test the hypothesis are discussed. Primary data from cell phones regarding miles traveled, number of times leaving home, etc., are among the possible indirect measures.

Results: The rapid ability of the SARS/CoV-2 virus to spread through society suggests that it may cause behavioral changes of the host to increase its transmission. Numerous cases of super spreader events are noted that have provided meaningful measures of host manipulation.

Conclusion: In the case of SARS/CoV-2, the largest advantage of the pathogen is likely that between 50% and 70% of those infected are asymptomatic (John's Hopkins Coronavirus Resource Center, John's Hopkins University Corona Virus Resource Center. Available at https://coronavirus.jhu.edu/map.html , 2020). This component is a threat to elderly individuals and those immunocompromised who are more likely to have severe complications from the virus and die. To spread within these groups, a seemingly healthy host is necessary to carry the virus to them. The goal of the virus is not to kill the host, but to survive and reproduce.

Keywords: Asymptomatic; Coronavirus; Herd immunity; Host manipulation; Pandemic; R0; SARS/CoV-2; Social distancing; Super spreader; Toxoplasmosis.

MeSH terms

  • Aged
  • Behavior Control
  • COVID-19*
  • Humans
  • SARS-CoV-2
  • Severe Acute Respiratory Syndrome*